'Test and treat' study shows second phase is finding more people with HIV and getting them onto treatment
Glecaprevir/pibrentasvir for hepatitis C can be safely administered with common antiretrovirals
Dolutegravir monotherapy fails to maintain HIV viral suppression, but dolutegravir + lamivudine looks good
DAA therapy cures most people with HIV/HCV co-infection with decompensated cirrhosis or liver transplants
D:A:D study – long-term use of darunavir/ritonavir modestly increases the risk of cardiovascular disease
Simple risk score can identify gay men who may have acute HIV infection
Researchers report case of bone marrow transplant patient off ART for 288 days without HIV rebound
New HIV capsid inhibitors show high potency and prolonged activity in early studies
